A chronic autoimmune disease of the skin, called scleroderma, is not contagious or infectious and often not harmful. However, when this connective tissue disorder involves any internal organs, it can ...
What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...
DEAR MAYO CLINIC: I'm a 50-year-old woman recently diagnosed with scleroderma. What causes it, and can anything stop its progression? What medications are available, and at what point should I begin ...
JACKSONVILLE BEACH, Fla. — Scleroderma is a rare disease that afflicts less than one-tenth of one percent of Americans. It cannot be cured, but doctors at Mayo Clinic have found success in a treatment ...
WASHINGTON -- First Bari Martz's fingers turned blue. Then she started gasping for breath, and her joints stiffened so that she couldn't even open her hands. Doctors diagnosed scleroderma, part of an ...
GRAND RAPIDS — Jean Hehrer, 50, had huge stressors in her life: losing her first husband to pancreatic cancer; moving to Michigan with her 14-year-old son; meeting and marrying a new man with three ...
Scientists are not quite sure why or how individuals develop scleroderma, and there is no current cure for the autoimmune disease. Stem cells may be the answer, at least for a better treatment option.
SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...
MEMPHIS, Tenn., Aug. 14 -- arGentis Pharmaceuticals, LLC announced today an agreement with The University of Tennessee Research Foundation to license the intellectual property surrounding the use of ...
Mycophenolate mofetil is associated with comparable treatment outcomes to methotrexate among patients with juvenile localized ...
Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease ...
The global systemic scleroderma treatment market expected to reach USD 2.2 billion by 2028 according to a new study by Report Ocean. The report “Systemic Scleroderma Treatment Market Report, By Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results